Imsapepimut

**Semantic type:** Amino Acid, Peptide, or Protein|Pharmacologic Substance

**Definition:** A second-generation peptide vaccine derived from the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) with potential immunomodulating and antineoplastic activities. Vaccination with imsapepimut may activate the immune system to induce an immune response against IDO-expressing tumor cells. This may restore the proliferation and activation of various immune cells including cytotoxic T-lymphocytes (CTLs), natural killer cells (NKs), and dendritic cells (DCs), and may eradicate IDO-expressing tumor cells through a CTL-mediated response. IDO, a cytosolic enzyme responsible for tryptophan catabolism and conversion of tryptophan into kynurenine, is overexpressed by a variety of tumor cell types and antigen presenting cells (APCs) and plays an important role in immunosuppression mainly through suppression of CTL activation.

**Synonyms:** - IDO Peptide Vaccine IO102 - IDO-derived Vaccine IO102 - IMSAPEPIMUT - IO 102 - IO-102 - IO102 - Imsamotide - Indoleamine 2,3-dioxygenase-derived Peptide Vaccine